RUS  ENG
Full version
JOURNALS // Zhurnal Vychislitel'noi Matematiki i Matematicheskoi Fiziki // Archive

Zh. Vychisl. Mat. Mat. Fiz., 2020 Volume 60, Number 4, Pages 590–600 (Mi zvmmf11058)

This article is cited in 9 papers

Optimization methods for solving inverse immunology and epidemiology problems

S. I. Kabanikhinab, O. I. Krivorot'koab

a Institute of Computational Mathematics and Mathematical Geophysics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia
b Novosibirsk State University, Novosibirsk, 630090 Russia

Abstract: Inverse problems for systems of nonlinear ordinary differential equations are studied. In these problems, the unknown coefficients and initial data must be found given additional information about the solution to the corresponding direct problems; this information is obtained by measurements made at some specified points in time. Examples of inverse immunology and epidemiology problems arising in the analysis of infectious diseases progression, in the study of HIV dynamics, and spread of tuberculosis in highly endemic regions taking treatment into account are discussed. In the case when the solution to the inverse problem is not unique, three approaches to the study of identifiability of mathematical models are considered. A numerical solution algorithm based on the minimization of a quadratic objective functional is proposed. At the first stage, neighborhoods of the global minimizers are found, and gradient methods are used at the second stage. The gradient of the objective functional is calculated by solving the corresponding adjoint problem. Numerical results are discussed.

Key words: inverse problems, ODE, identification of parameters, gradient method, gradient of functional, immunology, epidemiology.

UDC: 517.955.8

Received: 10.10.2019
Revised: 09.12.2019
Accepted: 16.12.2019

DOI: 10.31857/S0044466920040109


 English version:
Computational Mathematics and Mathematical Physics, 2020, 60:4, 580–589

Bibliographic databases:


© Steklov Math. Inst. of RAS, 2024